|
|
Volumn 48, Issue 6, 2003, Pages 1481-1483
|
|
Add-on or step-up trials for new drug development in rheumatoid arthritis: A new standard?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
GLUCOCORTICOID;
INFLIXIMAB;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
SULFAMETHOXAZOLE;
TRIMETHOPRIM;
COMBINATION CHEMOTHERAPY;
DRUG CHOICE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
PRIORITY JOURNAL;
REVIEW;
RHEUMATOID ARTHRITIS;
SIDE EFFECT;
TREATMENT PLANNING;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS;
DECISION MAKING;
DRUG THERAPY, COMBINATION;
DRUGS, INVESTIGATIONAL;
HUMANS;
METHOTREXATE;
RESEARCH DESIGN;
|
|
EID: 0037976830
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.11141 Document Type: Review |
|
Times cited : (39)
|
|
References (0)
|
